# CONCORDBIO — Concord Biotech Limited

> Concord Biotech Limited (CONCORDBIO) on the NSE: 747 sessions of split-adjusted history from 2023.

Canonical: https://patternsradar.com/s/CONCORDBIO

## Latest session

- Close: 1,571.3 INR (-0.34% on the day), 2026-08-21
- Delivery: 33.99% of volume taken to demat (20-day average 43.95%)
- Volume: 94.2K shares, turnover ₹14.8Cr
- Relative volume: 0.42× of its own 20-day average

## Technicals

- RSI(14): 74.89
- ATR(14): 53.08
- SMA 50: 1,357.97, SMA 200: 1,264.98
- 52-week range: 987 – 1,801.9 (-12.8% from the high)

## Performance

- 1 week 8.27%, 1 month 23.87%, 3 months 36.24%
- 6 months 35.01%, 1 year -3.81%

## Fundamentals

- Market cap: 16,438.3 crore
- P/E (TTM): 60.24 — NULL when trailing earnings are negative or unfiled, never a misleading number
- EPS (TTM): 26.08 INR, split-adjusted to match the price series
- Revenue growth: 26.23% YoY, -21.03% QoQ
- Profit growth: 30.96% YoY, -34.78% QoQ

Compound annual growth, trailing-twelve-month against the same measure N years earlier:

| Window | Revenue | Profit |
| --- | --- | --- |
| 2y | 3.34% | -6.66% |

## Quarterly results

Last 8 filed quarters, consolidated basis, in rupees crore as filed.

| Quarter | Revenue | Total expenses | Profit before tax | Net profit | EPS | Net margin |
| --- | --- | --- | --- | --- | --- | --- |
| 2024-09-30 | 310.2 | 186.9 | 133.3 | 95.7 | 9.15 | 30.87% |
| 2024-12-31 | 244.2 | 159.6 | 99.3 | 75.9 | 7.26 | 31.09% |
| 2025-03-31 | 429.9 | 254.2 | 185.1 | 140.4 | 13.42 | 32.66% |
| 2025-06-30 | 204 | 160.4 | 57.2 | 44.1 | 4.21 | 21.6% |
| 2025-09-30 | 247.1 | 177 | 83.4 | 63.1 | 6.03 | 25.53% |
| 2025-12-31 | 277.8 | 197.6 | 86.9 | 63.6 | 6.08 | 22.91% |
| 2026-03-31 | 326.1 | 227.2 | 114.3 | 88.5 | 8.46 | 27.13% |
| 2026-06-30 | 257.5 | 193.2 | 77.1 | 57.7 | 5.52 | 22.41% |

A quarterly filing with NSE carries a profit and loss only. There is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure in this dataset. EPS is restated onto the split-adjusted basis the price series uses; every rupee figure is exactly as filed.

## Shareholding

As filed for 2026-06-30:

- Promoter: 44.08%
- Public: 55.92%

Institutional and pledge percentages come from a filing stage whose backfill has reached about 1% of instruments, so they are absent here rather than zero.

## Recent filings

- 2026-07-31: results for 2026-06-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_181282_31072026183610_iXBRL_WEB.html
- 2026-07-24: dividend
- 2026-07-18: shareholding for 2026-06-30 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1696145_18072026042302_WEB.xml
- 2026-05-29: results for 2026-03-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_164072_29052026202228_iXBRL_WEB.html
- 2026-04-18: shareholding for 2026-03-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1653868_18042026104616_WEB.xml
- 2026-02-11: results for 2025-12-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_142148_11022026200838_iXBRL_WEB.html
- 2026-01-21: shareholding for 2025-12-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1606456_21012026091459_WEB.xml
- 2025-11-13: results for 2025-09-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_127459_13112025192059_iXBRL_WEB.html

Dated by the day the company broadcast the filing. 29 events are indexed for this instrument.

## About the instrument

- Listed: 2023-08-18 — latest session 2026-08-21 (747 sessions)
- ISIN: INE338H01029
- Series: EQ
- Liquidity rank: #604 by 20-day average turnover — not index membership

Delivery figures come from NSE's daily reports and are unavailable for older sessions. Prices are end-of-day, split- and bonus-adjusted, from the eod2 dataset.

Charts and the full bar history are on the rendered page: https://patternsradar.com/s/CONCORDBIO.